南宫NG·28(中国)相信品牌力量

Beijing, China - On October 27, MicroPort Endovascular (Shanghai) Co., Ltd. ("MicroPort® Endovascular") was granted the "Outstanding Contribution to Performance Improvement Award" and its project "PLUS"（Portfolio Life-cycle United Stimulation）was granted the "Best Practice of Performance Improvement Award" by the International Society for Performance Improvement – China ("ISPI-China") in the 6th China Performance Improvement Forum held in Beijing. The forum aims to distribute the latest updates related with performance improvement and provides a platform for companies that stand out for performance improvement to share their experience and development stories.

China Performance Improvement Forum, the annual event of ISPI-China held for six consecutive years, represents the highest-level leaders meeting in the field of performance improvement in Asia. In 2016, all awards given by China Performance Improvement Expert Committee and ISPI-China are jointly selected by a panel of entrepreneurs and academicians according to principles of performance improvement by the ISPI and other international standards, via assessments of results, systematic thinking, added value, partnership cooperation, determination of requirements and opportunities. The "Outstanding Contribution to Performance Improvement Award" was created to honor individuals, organizations and companies for their contributions to the developments of ISPI and ISPI-China. The "Best Practice of Performance Improvement Award" aims to discover and honor individuals or companies that stand out for their achievements in performance improvement practices.

"PLUS" is the performance improvement project MicroPort® Endovascular has been developing and practicing since 2012 with the purpose to inspire the motivation and creativity of its R&D staff, and to guide them to accelerate the R&D process and deliver more high-tech and high-added-value products with lower cost. "PLUS" is designed for multiple medical device projects covering the whole life-cycle of a medical device from the formation of the initial concept to the phase-out of the product. "PLUS" manages the performance within one project or between multiple projects. It will improve the overall performance of the portfolio, and will enhance awareness of long-term cooperation between team members as well as their identity with the project management.

MicroPort Scientific Corporation (the "Group") is a leading medical device company with business focusing on innovating, manufacturing, and marketing high-quality and high-end medical devices globally. With a diverse portfolio of products now being used at an average rate of one for every 15 seconds in thousands of major hospitals around the world, the Group maintains world-wide operations in a broad range of business segments including Cardiovascular, Orthopedic, Electrophysiological, Endovascular, Neurovascular, Surgical, Diabetes Care and Endocrinal Management, and others. MicroPort® is dedicated to becoming a patient oriented global enterprise improve and reshape patient lives through application of innovative science and technology.